⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3538842 | 1.00 | — | — | |
| SCHEMBL13784614 | 1.00 | — | — | |
| SCHEMBL28068345 | 0.87 | — | — | |
| SCHEMBL27798770 | 0.68 | — | — | |
| SCHEMBL657595 | 0.67 | — | — | |
| SCHEMBL834790 | 0.67 | — | — | |
| SCHEMBL834791 | 0.67 | — | — | |
| SCHEMBL2782776 | 0.66 | — | — | |
| SCHEMBL5100810 | 0.66 | — | — | |
| SCHEMBL5510804 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118330121-A | Method for determining characteristic aroma components of rambutan seed oil by combining GC-MS and GC-IMS | 海南大学 | 2024-07-12 | — | — | CN | disclosed |
| US-11925455-B2 | Methods for diagnosing malaria | WASHINGTON UNIVERSITY (US) | 2024-03-12 | — | — | US | disclosed |
| CN-115445433-A | Waste gas treating agent and preparation method and application thereof | 深圳市天得一环境科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| US-20210128016-A1 | METHODS FOR DIAGNOSING MALARIA | WASHINGTON UNIVERSITY (US) | 2021-05-06 | — | — | US | disclosed |
| US-7816385-B2 | Dimeric dicarboxylic acid derivatives, their preparation and use | HIGH POINT PHARMACEUTICALS, LLC (US) | 2010-10-19 | — | — | US | disclosed |
| US-7220877-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2007-05-22 | — | — | US | disclosed |
| US-7202213-B2 | Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders | NOVO NORDISK A/S (DK) | 2007-04-10 | — | — | US | disclosed |
| US-6972294-B1 | Compounds, their preparation and use | NOVO NORDISK, A/S (DK) | 2005-12-06 | — | — | US | disclosed |
| US-6867218-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2005-03-15 | — | — | US | disclosed |
| US-20050026223-A1 | Method and compositions for increasing bone mass | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2005-02-03 | — | — | US | disclosed |
| US-20010031764-A1 | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR) | JEPPESEN LONE (DK) | 2001-10-18 | — | — | US | disclosed |
| US-20010031762-A1 | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) | JEPPESEN LONE (DK) | 2001-10-18 | — | — | US | disclosed |
| US-20010029256-A1 | New compounds, their preparation and use | LEGO A/S (DK) | 2001-10-11 | — | — | US | disclosed |
| US-6300339-B1 | USEFUL FOR THRERAPY AND/OR PROPHYLAXIS OF INSULIN RESISTANCE (TYPE 2 DIABETES), IMPAIRED GLUCOSE TOLERANCE, DYSLIPIDEMIA, HYPERTENSION, OBESITY, INSULIN RESISTANCE, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERLIPIDEMIA, CORONARY ARTERY DISEASE | NOVO NORDISK A/S (DK) | 2001-10-09 | — | — | US | disclosed |
| US-6248781-B1 | ANTIDIABETIC AGENTS; DIETETICS | NOVO NORDISK A/S (DK) | 2001-06-19 | — | — | US | disclosed |
| US-6214820-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | NOVO NORDISK A/S (DK) | 2001-04-10 | — | — | US | disclosed |
| US-6197833-B1 | Neuroprotective effects of polycyclic phenolic compounds | APOLLO BIOPHARMACEUTICS, INC. | 2001-03-06 | — | — | US | disclosed |
| US-6083957-A | FOR TREATMENT OF GLAUCOMA, GASTROINTESTINAL MOTILITY DISORDERS, IRRITABLE BOWEL SYNDROME (IBS), URINARY BLADDER DISORDERS AND RESPIRATORY DISORDERS | NOVO NORDISK A/S (DK) | 2000-07-04 | — | — | US | disclosed |
| US-5914338-A | COMPOUNDS OF THE GENERAL FORMULA 1-(3-(SUBSTITUTED PHENYL ALKYNYL(OXY OR THIO))-1,2,5-THIADIAZOL-4-YL) -4-AZATRICYCLO(2.2.1.0(2,6))HEPTANE; CENTRAL NERVOUS SYSTEM DISEASES CAUSED BY MUSCARINIC CHOLINERGIC SYSTEM DISORDERS | NOVO NORDISK (DK) | 1999-06-22 | — | — | US | disclosed |
| US-5859001-A | Neuroprotective effects of polycyclic phenolic compounds | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1999-01-12 | — | — | US | disclosed |